- Home
- CAKE vs ZLAB Comparison
CAKE vs ZLAB Comparison
Compare CAKE & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAKE
- ZLAB
- Stock Information
- Founded
- CAKE 1972
- ZLAB 2013
- Country
- CAKE United States
- ZLAB China
- Employees
- CAKE N/A
- ZLAB N/A
- Industry
- CAKE Restaurants
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- CAKE Consumer Discretionary
- ZLAB Health Care
- Exchange
- CAKE Nasdaq
- ZLAB Nasdaq
- Market Cap
- CAKE 2.8B
- ZLAB 3.6B
- IPO Year
- CAKE 1992
- ZLAB 2017
- Fundamental
- Price
- CAKE $64.12
- ZLAB $35.17
- Analyst Decision
- CAKE Hold
- ZLAB Buy
- Analyst Count
- CAKE 14
- ZLAB 5
- Target Price
- CAKE $53.50
- ZLAB $54.28
- AVG Volume (30 Days)
- CAKE 1.4M
- ZLAB 987.9K
- Earning Date
- CAKE 07-30-2025
- ZLAB 08-05-2025
- Dividend Yield
- CAKE 1.69%
- ZLAB N/A
- EPS Growth
- CAKE 45.67
- ZLAB N/A
- EPS
- CAKE 3.19
- ZLAB N/A
- Revenue
- CAKE $3,617,673,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- CAKE $7.04
- ZLAB $44.07
- Revenue Next Year
- CAKE $6.10
- ZLAB $49.13
- P/E Ratio
- CAKE $19.99
- ZLAB N/A
- Revenue Growth
- CAKE 4.42
- ZLAB 43.72
- 52 Week Low
- CAKE $33.50
- ZLAB $16.01
- 52 Week High
- CAKE $64.55
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- CAKE 74.30
- ZLAB 48.52
- Support Level
- CAKE $59.16
- ZLAB $34.55
- Resistance Level
- CAKE $61.21
- ZLAB $36.73
- Average True Range (ATR)
- CAKE 1.61
- ZLAB 1.35
- MACD
- CAKE 0.25
- ZLAB -0.61
- Stochastic Oscillator
- CAKE 100.00
- ZLAB 7.35
About CAKE Cheesecake Factory Incorporated (The)
Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.